Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.55 CAD
Change Today 0.00 / 0.00%
Volume 90.0K
As of 1:36 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

medworxx solutions inc (MWX) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/3/15 - C$0.69
52 Week Low
12/10/14 - C$0.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDWORXX SOLUTIONS INC (MWX)

Related News

No related news articles were found.

medworxx solutions inc (MWX) Related Businessweek News

No Related Businessweek News Found

medworxx solutions inc (MWX) Details

Medworxx Solutions Inc. provides health information technology solutions to hospitals in Canada, the United States, the United Kingdom, France, and Australia. It develops and sells technologies that are used to assist health care practitioners’ abilities to communicate, aggregate, and analyze knowledge. The company offers Medworxx patient flow solutions, which enable hospitals to assess and analyze patient flow barriers, interruptions, and delays; and to optimize care intensity, advance care plans, and to gain insight into strategic indicators of quality and performance, as well as provides electronic bed management and independent assessment components; and Medworxx Compliance and Education platform that enables healthcare organizations to create and deploy relevant content. It also provides maintenance, hosting, and consulting services. Medworxx Solutions Inc. was founded in 2004 and is headquartered in Toronto, Canada.

Founded in 2004

medworxx solutions inc (MWX) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: C$256.7K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: C$190.0K
Senior Vice President of Sales
Total Annual Compensation: C$155.0K
Vice President of Product Development & Servi...
Total Annual Compensation: C$163.6K
Vice President of Patient Flow Process Improv...
Total Annual Compensation: C$150.9K
Compensation as of Fiscal Year 2014.

medworxx solutions inc (MWX) Key Developments

Medworxx Solutions Inc. Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Medworxx Solutions Inc. announced earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company’s net income was $148,508 compared to net loss of $430,238 for the three months ended June 30, 2014. Revenue was $2,018,438, representing an increase of 39.9% over revenues of $1,443,007 in the same period last year. For the six months, net income was $319,864 compared to loss of $742,188 for the six months ended June 30, 2014, a record high for the company for the first half of the year. Revenue was $4,028,941, representing an increase of 32.4% over revenues of $3,042,312 in the same period last year, a record high for the company for the first half of the year.

NHS England Identifies Medworxx as an Official Clinical Utilisation Review (CUR) Provider

Medworxx Inc. announced that NHS England has selected Medworxx and three other patient flow solution providers as CUR Preferred Bidders. In 2014 NHS England introduced a Commissioning for Quality and Innovation scheme (CQUIN) to require mandatory adoption of CUR as a core capability to ensure the provision of safe and cost effective care. After an extensive RFP process, NHS England named four vendors to support CUR technology for specialised services and critical care. This announcement confirms that NHS England and preferred vendors now have a Framework Agreement in place and allows NHS Trusts to contract directly with vendors from the framework without repeating the usual procurement processes using CQUIN funds. The Framework Agreement also confirms that only products from these four vendors will be recognized for CQUIN funding. The framework can also be used by all other NHS provider and commissioner organizations in England.

Medworxx Patient Flow Solution Continues to Expand in the UK with Adoption from Basildon and Thurrock University Hospitals NHS Foundation Trust

Medworxx Solutions Inc. announced Basildon and Thurrock University Hospitals NHS Foundation Trust (BTUH) has licensed the Medworxx Clinical Criteria Module to be installed in a multi-phase Clinical Utilisation Review (CUR) deployment across the Acute Trust and ultimately into neighbouring Community based services, covering close to 700 beds across several locations. BTUH has been successfully appointed by NHS England as an early Implementer of the National CUR CQUIN Scheme and provides an extensive range of acute services for 405,000 people living in south-west Essex. The Essex Cardiothoracic Centre is also part of the Trust, providing a full range of tertiary cardiothoracic services for the whole county and further afield. Phase one of the locally hosted implementation includes a strategic rollout across the Cardiothoracic Centre’s three wards, with Phase two including all general medicine beds.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MWX:CN C$0.55 CAD 0.00

MWX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MWX.
View Industry Companies

Industry Analysis


Industry Average

Valuation MWX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDWORXX SOLUTIONS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at